| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0009 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.002 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.13 | 0.003 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |